Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
New Study: Robot-Assisted Hysterectomy Offers Similar (But Pricier) Results Compared to Laparoscopic Counterpart
According to the National Institutes of Health, one in three women in the U.S. will undergo a hysterectomy by the age of 60.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
Though selected in order to give a platform to lesser recognized businesses, the companies presenting demonstrated the vast diversity of the healthcare and life science spaces.
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
A number of companies are developing minimally invasive devices that produce the weight-reducing effects of a gastric bypass minus the actual surgery.